{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:39:54Z","timestamp":1791545994741,"version":"4.3.4"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>Beside its widely studied role in the pathogenesis of Alzheimer's disease (AD), \u03b2-amyloid (A\u03b2) is a normal and soluble product of neuronal metabolism that regulates several key physiological functions, exerting neuromodulatory effects on synaptic plasticity, memory, and neurotransmitter release. Such effects have been observed to occur in a hormetic fashion, with A\u03b2 exhibiting a dual role influenced by its concentration, the different isoforms, or aggregation forms of the peptide. However, to date, our knowledge about the physiological functions of A\u03b2 and, in particular, its modulatory role on synaptic activity and neurotransmission in the normal brain is fragmentary, thus hindering a clear comprehension of the biological mechanisms underlying the derangement from function to dysfunction. In particular, according to the amyloid cascade hypothesis, the switch from physiology to pathology is linked to the abnormal increase in A\u03b2 levels, due to an imbalance in A\u03b2 production and clearance. In this regard, increased A\u03b2 levels have been hypothesized to induce early defects in synaptic function and such alterations have been suggested to account, at least in part, for the onset of neuropsychiatric symptoms (e.g., apathy, anxiety, changes in mood, depression, and agitation\/aggression), frequently observed in the prodromal stage of AD. Therefore, understanding the biological mechanisms underlying early synaptic alterations in AD is a key starting point to frame the relevant time windows for AD treatment and to gain insight into AD etiopathogenesis.<\/jats:p>","DOI":"10.3389\/fnmol.2021.635880","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T06:30:08Z","timestamp":1614148208000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["(Dys)regulation of Synaptic Activity and Neurotransmitter Release by \u03b2-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis"],"prefix":"10.3389","volume":"14","author":[{"given":"Francesca","family":"Fagiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Racchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/nn.2433","article-title":"Amyloid-B as a positive endogenous regulator of release probability at hippocampal synapses","volume":"12","author":"Abramov","year":"2009","journal-title":"Nat. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chembiol.2012.02.003","article-title":"Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships","volume":"19","author":"Bemporad","year":"2012","journal-title":"Chem. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3233\/JAD-150181","article-title":"Associations between neuropsychiatric symptoms and cerebral amyloid deposition in cognitively impaired elderly people","volume":"49","author":"Bensamoun","year":"2015","journal-title":"J. Alzheimer's Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnagi.2018.00118","article-title":"The physiological roles of amyloid-\u03b2 peptide hint at new ways to treat Alzheimer's disease","volume":"10","author":"Brothers","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-\u03b2 levels in vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-190771","article-title":"Amyloid-\u03b2 and synaptic vesicle dynamics: a cacophonic Orchestra","volume":"72","author":"Fagiani","year":"2019","journal-title":"J. Alzheimer's Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1523\/JNEUROSCI.1736-09.2009","article-title":"\u03b2-amyloid monomers are neuroprotective","volume":"29","author":"Giuffrida","year":"2009","journal-title":"J. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.neuroscience.2010.01.058","article-title":"Specific inhibitory effect of amyloid-\u03b2 on presynaptic muscarinic receptor subtypes modulating neurotransmitter release in the rat nucleus accumbens","volume":"167","author":"Grilli","year":"2010","journal-title":"Neuroscience"},{"key":"B10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neurobiolaging.2018.06.025","article-title":"The effect of amyloid-\u03b2 peptide on synaptic plasticity and memory is influenced by different isoforms, concentrations, and aggregation status","volume":"71","author":"Gulisano","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1038\/s41380-018-0323-y","article-title":"Association of anxiety with subcortical amyloidosis in cognitively normal older adults","volume":"25","author":"Hanseeuw","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/archneurol.2011.235","article-title":"Effects of age and amyloid deposition on A\u03b2 dynamics in the human central nervous system","volume":"69","author":"Huang","year":"2012","journal-title":"Arch. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"22908","DOI":"10.1074\/jbc.271.37.22908","article-title":"Analysis of heterogeneous \u03b2A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay","volume":"271","author":"Ida","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"147r","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","article-title":"Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment","volume":"12","author":"Ismail","year":"2016","journal-title":"Alzheimer's Dement."},{"key":"B17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1180962","article-title":"Amyloid-\u03b2 dynamics are regulated by orexin and the sleep-wake cycle","volume":"326","author":"Kang","year":"2009","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1460-9568.2010.07116.x","article-title":"\u03b2-Amyloid activates presynaptic \u03b17 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: involvement of lipid rafts","volume":"31","author":"Khan","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"32553","DOI":"10.1038\/srep32553","article-title":"Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric A\u03b242: an early index of Alzheimer's disease","volume":"6","author":"Koppensteiner","year":"2016","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.phrs.2018.11.018","article-title":"Beta-amyloid short- and long-term synaptic entanglement","volume":"139","author":"Lanni","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.bbr.2017.11.017","article-title":"Subtle behavioral changes and increased prefrontal-hippocampal network synchronicity in APP NL\u2013G\u2013F mice before prominent plaque deposition","volume":"364","author":"Latif-Hernandez","year":"2019","journal-title":"Behav. Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fnmol.2017.00221","article-title":"Physiological concentrations of amyloid beta regulate recycling of synaptic vesicles via alpha7 acetylcholine receptor and CDK5\/calcineurin signaling","volume":"10","author":"Lazarevic","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/alz.12007","article-title":"Mild behavioral impairment is associated with \u03b2-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals","volume":"16","author":"Lussier","year":"2020","journal-title":"Alzheimer's Dement."},{"key":"B25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.nbd.2017.06.011","article-title":"Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid","volume":"106","author":"Marsh","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS \u03b2-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0116802","DOI":"10.1371\/journal.pone.0116802","article-title":"Cerebrospinal fluid \u03b2-amyloid1-42 levels in the differential diagnosis of Alzheimer's disease - systematic review and meta-analysis","volume":"10","author":"Mo","year":"2015","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/acn3.469","article-title":"Efficacy and safety of anti-amyloid-\u03b2 immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis","volume":"4","author":"Mo","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/jnnp-2013-306110","article-title":"Apathy correlates with prefrontal amyloid \u03b2 deposition in Alzheimer's disease","volume":"85","author":"Mori","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-2010-1299","article-title":"Specific neuromodulatory actions of amyloid-beta on dopamine release in rat nucleus accumbens and caudate putamen","volume":"19","author":"Mura","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e29661","DOI":"10.1371\/journal.pone.0029661","article-title":"Dual effect of beta-amyloid on \u03b17 and \u03b14\u03b22 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus","volume":"7","author":"Mura","year":"2012","journal-title":"PLoS ONE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer's disease and the amyloid-\u03b2 peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimer's Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fnagi.2014.00166","article-title":"Effects of soluble \u03b2-amyloid on the release of neurotransmitters from rat brain synaptosomes","volume":"6","author":"Olivero","year":"2014","journal-title":"Front Aging Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"14745","DOI":"10.1073\/pnas.0905127106","article-title":"Structure-neurotoxicity relationships of amyloid \u03b2-protein oligomers","volume":"106","author":"Ono","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"eaam8661","DOI":"10.1126\/scisignal.aam8661","article-title":"Activation of CaMKIV by soluble amyloid-\u03b21-42 impedes trafficking of axonal vesicles and impairs activity-dependent synaptogenesis","volume":"10","author":"Park","year":"2017","journal-title":"Sci. Signal."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/sj.npp.1301485","article-title":"Acute \u03b2-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens","volume":"33","author":"Preda","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/ana.22313","article-title":"Endogenous amyloid-\u03b2 is necessary for hippocampal synaptic plasticity and memory","volume":"69","author":"Puzzo","year":"2011","journal-title":"Ann. Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-\u03b2 positively modulates synaptic plasticity and memory in hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e4320","DOI":"10.1371\/journal.pone.0043201","article-title":"Amyloid-\u03b2 acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2","volume":"7","author":"Russell","year":"2012","journal-title":"PLoS ONE"},{"key":"B40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12868-018-0446-8","article-title":"Cognitive and emotional alterations in app knock-in mouse models of A\u03b2 amyloidosis","volume":"19","author":"Sakakibara","year":"2018","journal-title":"BMC Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S1474-4422(19)30480-6","article-title":"A resurrection of aducanumab for Alzheimer's disease","volume":"19","author":"Schneider","year":"2020","journal-title":"Lancet Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/359325a0","article-title":"Isolation and quantification of soluble Alzheimer's \u03b2-peptide from biological fluids","volume":"359","author":"Seubert","year":"1992","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.jmb.2007.02.093","article-title":"The Alzheimer's peptides A\u03b240 and 42 adopt distinct conformations in water: a combined MD \/ NMR Study","volume":"368","author":"Sgourakis","year":"2007","journal-title":"J. Mol. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's Dement."},{"key":"B45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3233\/JAD-170632","article-title":"Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group","volume":"62","author":"Taragano","year":"2018","journal-title":"J. Alzheimer's Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"34373","DOI":"10.1074\/jbc.M111.241299","article-title":"Role of key aromatic residues in the ligand-binding domain of \u03b17 nicotinic receptors in the agonist action of \u03b2-amyloid","volume":"286","author":"Tong","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A\u03b2 oligomers - a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J. Neurochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"\u03b2-Amyloid1-42 binds to \u03b17 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.trci.2018.10.001","article-title":"Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia","volume":"4","author":"Willis","year":"2018","journal-title":"Alzheimer's Dement"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.celrep.2015.07.044","article-title":"Amyloid-\u03b2 oligomers may impair SNARE-mediated exocytosis by direct binding to syntaxin 1a","volume":"12","author":"Yang","year":"2015","journal-title":"Cell Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fphar.2012.00146","article-title":"Beta amyloid differently modulate nicotinic and muscarinic receptor subtypes which stimulate in vitro and in vivo the release of glycine in the rat hippocampus","volume":"3","author":"Zappettini","year":"2012","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2021.635880\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T06:30:09Z","timestamp":1614148209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2021.635880\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":51,"alternative-id":["10.3389\/fnmol.2021.635880"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2021.635880","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"article-number":"635880"}}